Novartis | NOVN - Ordinary Share Capital

Stock Price
113.70
Daily Change
-2.58 -2.22%
Monthly
-4.95%
Yearly
22.87%
Q2 Forecast
111.47

Novartis reported $1.91B in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alcon AG USD 487.4M 7.2M Dec/2025
Almirall EUR 214.79M 0 Dec/2025
Amgen USD 539M 1000K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Autolus Therapeutics Ltd USD 266.14M 1.88K Sep/2025
Bayer EUR 982.42M 0 Dec/2025
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Fresenius EUR 563.24M 0 Sep/2025
Fresenius Medical Care EUR 279.29M 10.56M Dec/2025
Galapagos EUR 65.9M 0 Dec/2025
Genmab DKK 61.62M 52K Dec/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
GRIFOLS EUR 680.58M 846K Dec/2025
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
J&J USD 2.41B 1.74M Dec/2025
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Novartis USD 1.91B 10.64M Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Novo Nordisk DKK 4.44B 0 Dec/2025
Orion EUR 140.87M 173K Mar/2026
Pfizer USD 5.69B 1000K Sep/2025
Philips EUR 951.29M 310K Dec/2025
Recordati EUR 205.83M 270K Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
UCB EUR 190.36M 365.15K Dec/2025